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Abstract Cysteine-string proteins (Csps) are vesicle proteins
involved in exocytosis of synaptic vesicles in Drosophila and
modulation of presynaptic calcium influx. As both the contribu-
tion of calcium channel regulation to the role of Csp in exocytosis
and a function of Csp outside the nervous system are unknown,
we studied its function in endocrine exocytosis from large dense
core vesicles (LDCVs) using insulin-secreting pancreatic L-cells.
Csps were expressed in primary and derived L-cell lines on
insulin-containing LDCVs. Suppression of Csp expression
reduced not only depolarisation induced insulin release but also
exocytosis in permeabilised cells directly stimulated by Ca2+.
Thus, Csp is a secretory granule protein and is required for
endocrine exocytosis independent of the modulation of trans-
membrane calcium fluxes.
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1. Introduction
Exocytosis constitutes the ¢nal step in regulated secretion
[1]. This process involves macromolecular complexes and their
highly orchestrated assembly, rearrangement and disassembly
constitute a key part of the exocytotic process [2]. Despite
progress in the identi¢cation of components of the exocytotic
machinery in recent years, numerous proteins still await as-
signment of a speci¢c role. The cysteine-string proteins (Csps)
were ¢rst discovered as presynaptic proteins in Drosophila and
a densely clustered string of 12^15 cysteine residues gave rise
to their name [3]. The fatty acylation of these residues is
thought to tether Csps to synaptic vesicle membranes as
shown in Torpedo [4].
Csps are involved in neurotransmission [5], as deletion of
the Csp gene in Drosophila causes a temperature sensitive
block of synaptic transmission followed by paralysis and pre-
mature death [6,7]. Oocyte expression studies indicate that
Csps may modulate presynaptic Ca2 channels [8] and thereby
interfere with Ca2 in£ux required for exocytosis. Moreover
detailed analysis of Csp mutant Drosophila strains revealed a
major defect in calcium entry [9^11].
Similar to neuroexocytosis, insulin release from large dense
core vesicles in pancreatic L-cells is triggered by calcium in£ux
through voltage dependent channels [12]. Likewise, insulin
exocytosis requires the function of known protein components
of the exocytotic machinery such as synaptobrevin/VAMP
[13,14], syntaxin [15,16], K-SNAP [17], SNAP-25 [18] and syn-
aptotagmin [19,20]. We have therefore used insulin-secreting
cells as a model system to investigate whether Csp is involved
in exocytosis of LDCVs and whether its putative function
may involve modulation of Ca2-in£ux.
2. Materials and methods
2.1. Materials
Streptolysin-O was produced and puri¢ed as described [21]. 5-N-
Ethyl-N-isopropyl-amiloride was obtained from Sigma (Wallisellen,
Switzerland). Csp1 and Csp2 cDNA sequences were cloned from bo-
vine adrenal chroma⁄n cells and ligated into the BamHI/EcoRI sites
of pcDNA3 (Invitrogen, Leek, The Netherlands) [22] and Csp1 anti-
sense cDNA was constructed by ligation of the complete coding se-
quence of Csp1 into the BamHI/HindIII sites of pcDNA3.1(3) (In-
vitrogen). pNHE3, encoding the NHE3 cell speci¢c and amiloride
insensitive human Na/H antiport, was kindly provided by Dr J.
Pouyssegur (Nice, France) [23]. The following monoclonal antibodies
were used: anti-synaptophysin/SVP38 (Boehringer, Rotkreuz, Switzer-
land), anti-VAMP (kindly provided by Dr R. Jahn, Goettingen, Ger-
many), anti-SNAP-25 (Sternberger Monoclonals, Baltimore, MD,
USA), anti-syntaxin 1 (Sigma) and anti-insulin (K36aC10, Sigma,
Buchs, Switzerland). Polyclonal antibody against rabbit Csp was
raised against recombinant Csp1 [22,24]. In immunoblots this poly-
clonal antibody recognised well 20 ng of recombinant GST-Csp1, but
did not detect up to 500 ng of GST-Csp2. Fluorescent second anti-
bodies were purchased from Pierce (Oud Beijerland, The Nether-
lands).
2.2. Western blotting and subcellular fractionation
To prepare crude membranes, cells were detached by incubation for
5 min at 37‡C with PBS containing 10 mM EDTA, centrifuged for 10
min at 4‡C at 14 000Ug, resuspended in ice-cold PBS-EDTA, soni-
cated and again centrifuged for 30 min at 4‡C at 14 000Ug. Western
blotting using 12% SDS-PAGE minigels, subcellular fractionation,
immuno£uorescence and confocal laser microscopy were performed
as described previously [19,25,26]. Primary antibodies were diluted
at 1:100 for immuno£uorescence. For immunoblotting the following
dilutions were used: anti-Csp1 1:1000; anti-SVP38 1:2000; anti-Na/
K 1:1000; anti-syntaxin 1:2000; anti-SNAP25 1:2000 and anti-
VAMP 1:10 000.
2.3. RT-PCR of Csp isoforms
Total RNA was prepared from whole rat brain, indicated cell lines
or primary cells by the use of Trizol (Gibco Life Sciences, Basel,
Switzerland) and cDNA was synthesised using AMV reverse tran-
scriptase (Promega, Catalys AG, Wallisellen, Switzerland). The fol-
lowing primers were used: 5P-AAGGATCCATGGCTGACCA-
GAGGCAGCG (sense, BamHI restriction site underlined), and
antisense 5P-CTCAAGCTTTTAGTTGAACCCGTCGGTGTG (Hin-
dIII restriction site underlined). PCR reactions were carried out with
FEBS 20992 27-10-98 Cyaan Magenta Geel Zwart
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 2 3 3 - 2
*Corresponding author. Fax: (41) (22) 702-5543.
E-mail: jochen.lang@medecine.unige.ch
Abbreviations: Csp, cysteine-string protein; HIT-T15, hamster insuli-
noma cells; INS-1E, rat insulinoma cells; LDCV, large dense core
vesicles; MIN6, mouse insulinoma cells; RT-PCR, reverse transcrip-
tion-polymerase chain reaction; SLMV, synaptic-like microvesicles;
SL-O, streptolysin-O; SV, synaptic vesicles; SVP38, synaptophysin
FEBS 20992 FEBS Letters 437 (1998) 267^272
an initial denaturation cycle at 95‡C for 3 min followed by 30 cycles at
95‡C (1 min), 52‡C (1 min) and 72‡C (2 min) using Taq polymerase
(Pharmacia Biotech, Daºbendorf, Switzerland). The puri¢ed PCR frag-
ments were digested with BamHI and HindIII, inserted into the cor-
responding sites of pcDNA3.1(3) vectors and used for the transfor-
mation of DH5K E. coli cells. The identity of the positive clones was
veri¢ed by sequencing of both strands.
2.4. Cell culture and transient transfection
Cell cultures of INS1-E, HIT-T15, MIN6 and RINm5F cells, prep-
aration of primary L-cells and cotransfections were performed as de-
scribed [19,25^31]. Brie£y, for cotransfections cells were plated in 24
wells at 200 000 cells/well and transfected 2 days later. To this end,
cells were washed with Mg2 and Ca2 free PBS. One Wl Transfectam
(Promega, Wallisellen, Switzerland) was complexed for 15 min with a
total of 5 Wg cDNA (equal amounts of reporter gene and Csp anti-
sense cDNA or control plasmid) in 400 Wl Dulbecco’s minimal essen-
tial medium. The mixture was added to the cells after aspiration of
PBS and exchanged for complete medium after 12 h. Experiments
implying co-transfected cells were performed after 8 days.
For release studies, cells were washed twice at 37‡C with Krebs-
Ringer-bicarbonate-HEPES bu¡er (KRB, with the following compo-
sition in mM: 134 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1 CaCl2,
5 NaHCO3, 25 HEPES, 0.1% bovine serum albumin, pH 7.4). There-
after cells were incubated for 10 min in KRB (basal) or KRB con-
taining 50 mM KCl (KCl) and subsequently supernatants were re-
moved, centrifuged at 4‡C and kept at 320‡C until human insulin
C-peptide assay by species speci¢c ELISA (Dako, Kuºssnacht, Switzer-
land) [15,19,29,31]. For streptolysin-O (SL-O) permeabilisation, cells
were washed at 37‡C with KG (140 mM potassium glutamate, 5 mM
NaCl, 7 mM MgS04, 5 mM Na2ATP, 0.4 mM EGTA, 20 mM
HEPES, pH 7.0). Permeabilisation was performed with recombinant
SL-O in 0.1 WM free Ca2 with KG/EGTA/CaCl2-bu¡er containing
5 mM ATP during 7 min resulting in at least 95% of cells permeable
to trypan blue [19,29,31]. Subsequently cells were exposed to 0.1 or
10 WM free Ca2 in KG/EGTA/CaCl2-bu¡er for 8 min in the presence
of 5 mM ATP.
For determination of expression levels of Csp, cotransfected cells
were puri¢ed by acid-load selection using a vector that encodes the
amiloride-resistant Na/H exchanger isoform NHE3 [23,32]. HIT-
T15 cells were co-transfected with pNHE3 and either pcDNA3 or Csp
antisense-cDNA as given above. The selection procedure was per-
formed as described [23] with some modi¢cations using ¢lter sterilized
bu¡ers. Brie£y, 2 days after cotransfection, cells were washed with
PBS and kept for 20 min in loading bu¡er (70 mM choline chloride,
50 mM NH4Cl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 5 mM
glucose, 15 mM HEPES, adjusted to pH 7.5 with Tris-base) at 37‡C
without CO2 supply. Subsequently cells were washed rapidly in wash
bu¡er (120 mM choline chloride, 5 mM KCl, 1 mM MgCl2, 1.8 mM
CaCl2, 5 mM glucose, 15 mM MOPS, adjusted to pH 7.0 with Tris-
base), kept for 1 h in recovery medium (120 mM NaCl, 5 mM KCl,
1 mM MgCl2, 1.8 mM CaCl2, 5 mM glucose, 15 mM MOPS, adjusted
to pH 7.0 with Tris-base, containing 10 WM 5-N-ethyl-N-isopropyl-
amiloride), washed again once with PBS and further incubated in
complete medium under normal culture conditions. The following
day cells were trypsinised to remove dead cells, reseeded at 0.4U106
cells/well and ¢nally cells were harvested 8 days after co-transfection
for immunoblots. Control cotransfection experiments using an en-
hanced green £uorescent protein expressing plasmid (peGFP) indi-
cated that about 90% of the selected cells expressed this cotransfected
marker.
2.5. Statistical analysis
Results are presented as mean þ S.E. from experiments performed
independently on at least three di¡erent cell preparations. Statistical
analysis was performed by Student’s two-tailed t-test for unpaired
data (2p).
3. Results and discussion
3.1. Expression of Csps in insulin secreting cells
We ¢rst examined whether Csps are expressed in the insu-
lin-secreting cell lines RINm5F, HIT-T15, INS-1E and MIN6
using a polyclonal anti-Csp antibody raised against recombi-
nant Csp1 (Fig. 1A). This antibody recognized a 35-kDa pro-
tein, as expected for Csp1, in immunoblots of crude mem-
branes from all insulin-secreting cell lines tested. As the
antibody recognizes only Csp1, but not the C-terminally trun-
cated splice variant Csp2 (see Section 2), we employed RT-
PCR to test for the expression of Csp2. As shown in Fig. 1B,
we obtained two amplicons of sizes expected for Csp1 and
Csp2 using RNA from rat brain, primary rat islet cells, ham-
ster HIT-T15 and rat INS-1E cells. Subcloning of the two
amplicons from rat islets into pcDNA3 and full length se-
quencing revealed them to be identical to the published se-
quences of rat Csp1 and Csp2 [22], respectively.
3.2. Subcellular distribution of Csps
In order to investigate the subcellular localisation of Csp1,
we performed subcellular fractionation of INS-1E cells on a
continuous sucrose density gradient (Fig. 2). This method
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Fig. 1. Expression of Csps in insulin secreting cells. A: Crude mem-
branes (20 Wg) from the indicated insulin-secreting cell lines
RINm5F, HIT-T15, INS-1E and MIN6 were separated by 12%
SDS-PAGE, transferred to a PVDF membrane and probed with a
polyclonal anti-Csp antibody. B: PCR ampli¢cation of Csp cDNA
from rat brain, rat islets and the derived clonal cell lines HIT-T15
and INS1-E. PCR was performed using primers corresponding to
the 5P and 3P ends of the Csp1 coding sequence. The size of the two
amplicons generated is compatible with Csp1 (598 bp) and Csp2
(666 bp). Their identity was further con¢rmed by subcloning and se-
quencing of both strands (see Section 3).
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permits the separation of two vesicle populations in L-cells :
the small synaptic vesicle-like microvesicles (SLMVs), carrying
GABA, and LDCVs containing insulin, the secretory granules
[33]. In endocrine cells the major part of synaptophysin im-
munoreactivity (SVP38) corresponds to early endocytotic
compartments, whereas a smaller amount re£ects the presence
of SLMVs [33,34]. SVP38 was restricted to fractions 8 and 9
(Fig. 2, upper panel), whereas insulin was detected mainly in
fractions 13^16 (Fig. 2, lower panel), indicating the presence
of secretory granules. Na/K ATPase, a marker protein for
plasma membranes, was found in fractions 11^13. Csps were
enriched mainly in fractions 8^10 and 13^16.
These ¢ndings were extended to primary pancreatic L-cells
and derived cell lines by confocal immunomicroscopy. In pri-
mary cells, in INS-1E cells and in HIT-T15 cells a granular
pattern of immunoreactivity for Csps was observed (Fig. 3A).
Double-staining with anti-Csp1 and with anti-insulin antibod-
ies revealed that insulin immunoreactivity largely colocalised
with immunostaining for Csp. In addition, a certain amount
of Csp immunoreactivity was localised to other cellular com-
partments and this was most prominent in primary L-cells.
Therefore we also investigated whether Csp and synaptophy-
sin immunoreactivity coincide. As shown in Fig. 3B, synapto-
physin typically yields a mainly perinuclear stain in accord-
ance with its predominant location on early endosomal
compartments [33,34]. Csp immunoreactivity hardly coincided
with the perinuclear synaptophysin immunoreactivity.
It may therefore be hypothesized that the comigration of
Csp with SVP38 positive vesicles in sucrose gradients might
re£ect the presence of Csp on SLMVs, but not on early en-
docytotic compartments, in analogy to its expression on exo-
cytotic vesicles in neurons [3,35]. More importantly, these
data indicate that Csp is present on insulin-containing secre-
tory granules and therefore may play a role in insulin exocy-
tosis. The expression of Csps on secretory granules observed
here is consistent with their previous localisation on large
dense core vesicles in neuroendocrine cells [24,36] and exo-
crine pancreas [37]. As our antibody recognises only the iso-
form Csp1, we cannot draw any direct conclusions on the
distribution of Csp2. However, transient expression of myc
epitope-tagged Csp1 and Csp2 yields a comparable subcellular
distribution of the two isoforms (H. Zhang and J. Lang,
manuscript in preparation).
3.3. E¡ect of transient expression of Csp-antisense DNA on
insulin secretion and exocytosis
In order to investigate the role of Csps in the exocytosis of
insulin, we employed transient antisense transfection in the
insulin-secreting hamster L-cell line HIT-T15. To test the ef-
fect of transient antisense transfection on the expression of
Csp, we puri¢ed cotransfected cells using coexpression of an
amiloride-insensitive Na/H antiport as selection marker fol-
lowed by a challenge with acid [23,32] (see Section 2). As
shown in Fig. 4A, cotransfection with Csp antisense cDNA
speci¢cally reduced the expression of Csp. In contrast, no
alteration was found in the levels of vesicular or plasma mem-
brane SNARE proteins known to be involved in insulin exo-
cytosis, such as syntaxin 1, SNAP-25 or VAMP [13,15,18].
To monitor the e¡ect of Csp anti-sense cDNA on secretion
and exocytosis, we exploited our cotransfection system using a
plasmid encoding human preproinsulin (phINS). The ensuing
release of the gene product human insulin C-peptide is used as
a reporter for insulin release from the cotransfected rodent
cells [15,19,25,29,31]. Intact cells were either exposed to
Krebs-Ringer bu¡er alone or stimulated by the addition of
50 mM KCl (Fig. 4B, upper panel), which leads to depolari-
zation-induced Ca2-in£ux through voltage-dependent Ca2
channels and secretion of the reporter gene product insulin
C-peptide. We observed that co-transfection with
pcDNA3asCsp (antisense) inhibited the release of human C-
peptide induced by 50 mM KCl by 52% as compared to co-
transfection with the control vector pcDNA3 (control).
The e¡ect of Csp suppression on insulin secretion in intact
cells does not permit de¢ning the steps at which the protein
normally interacts with the secretory pathway. The observed
inhibition of insulin secretion may be attributed to a variety of
mechanisms including di¡erences in Ca2 in£ux through volt-
age-dependent Ca2 channels. To bypass this step, we also
studied the e¡ects of antisense cDNA in streptolysin-O (SL-
O) permeabilised cells. In these permeabilised cells, ionic gra-
dients are abolished and the cytosolic Ca2 is clamped to
de¢ned values by the use of Ca2/EGTA bu¡ers
[19,26,31,38]. Furthermore, soluble second messengers such
as cAMP or IP3 no longer contribute to the observed response
[29]. As shown in Fig. 4B (lower panel), raising the concen-
tration of free Ca2 from basal levels of 0.1 WM to the max-
imally stimulatory levels of 10 WM [38] induced a threefold
increase in human insulin C-peptide release. Again, in cells
transiently transfected with Csp antisense cDNA (antisense),
Ca2 stimulated exocytosis was decreased to a similar extent
as in intact cells. These observations demonstrate an impor-
tant role for the secretory granule protein Csp in insulin exo-
cytosis independent from the modulation of ion £uxes
through plasma membrane Ca2 channels. Similarly, stable
overexpression of Csp1 in neuroendocrine PC12 resulted in
an increase in LDCV exocytosis which was not accompanied
by macroscopic changes in Ca2 in£ux and was still observed
in permeabilised cells [39].
Fig. 2. Subcellular localisation of Csp1. A postnuclear supernatant
from INS-1E cells was separated on a continuous sucrose density
gradient (0.4^2.0 M). Samples were taken from the top to the bot-
tom of the tube and analysed (S, postnuclear supernatant; 1^20,
fraction numbers). Upper panel: Distribution of Csp (Csp) as well
as Na/K-ATPase (Na/K), and synaptophysin (SVP38), markers
for plasma membrane or synaptic-like microvesicles/endocytotic
compartments, respectively. Lower panel: Distribution of insulin
(closed circles) as determined by RIA and total protein (dashed
line).
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Fig. 3. Localisation of Csp1 in pancreatic L-cells and derived cell lines. A: Primary islet cells, INS-1E cells or HIT-T15 cells were stained with
a rabbit polyclonal anti-Csps antibody (CSP) and mouse monoclonal anti-insulin antibody (INSULIN). Immunostaining of Csps was revealed
by using rhodamine-conjugated anti-rabbit IgG (red) and insulin staining was detected with a £uorescein-coupled anti-mouse IgG (green). Co-
localization results in yellow. Bar size indicated in the phase contrast equals 10 Wm. B: Primary islet cells, INS-1E cells or HIT-T15 cells were
stained with a polyclonal anti-Csp antibody and a monoclonal anti-synaptophysin antibody. Immunostaining of Csps was revealed by using
rhodamine-conjugated anti-rabbit IgG (red) and synaptophysin staining was detected with a £uorescein-coupled anti-mouse IgG (green).
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3.4. Conclusions
The molecular actions of Csps in neuroexocytosis of SVs
have been linked to the sites of Ca2 entry [6,7,34]. Deletion
of the Csp gene in Drosophila interrupts only depolarisation-
induced neurotransmitter release, but not exocytosis induced
independent of ion £uxes through presynaptic Ca2 channels
[9,10]. This excludes a failure of Ca2 action itself on the
exocytotic machinery. The apparent contradiction between
these observations and our results could be reconciled when
considering that presynaptic Ca2 channels may not only me-
diate Ca2 in£ux. They may, in addition, organise the phys-
ical site of exocytosis at regions of maximal calcium concen-
trations [40]. Indeed, the intracellular loop LII=III in the K1
subunit of presynaptic N- or P/Q-type Ca2 channels associ-
ates with the SNARE proteins syntaxin/SNAP-25/synaptobre-
vin and with synaptotagmin and is thereby linked to exocy-
totic vesicles [40^43]. Interestingly, it has recently been shown
by Leveque et al. [44] that Csp1 also interacts in vitro with the
same loop of presynaptic P/Q-type Ca2 channel. These ob-
servations lead to the proposal that Csp acts as a chaperone
[45,46] and assists the assembly, rearrangement or disassembly
of protein complexes at this speci¢c site of exocytosis [44].
Such a function of Csp may provide the molecular basis for
the initially proposed link between synaptic vesicles and pre-
synaptic Ca2 channels [35]. In contrast to neurons, L-type
Ca2 channels are mainly responsible for Ca2-in£ux causing
secretion in the endocrine L-cells [47] and L-type Ca2 chan-
nels functionally interact with SNARE proteins upon co-ex-
pression in Xenopus oocytes [48].
Collectively these observations and our results might pre-
dict that not only neuroexocytosis of SVs, but also exocytosis
of LDCVs in endocrine cells is physically linked to Ca2 entry
sites. Such a linkage was suggested by the polarised distribu-
tion of secretion and Ca2 in£ux in mouse L-cells [49]. As the
role of Csps in endocrine exocytosis of LDCVs has now been
established, future research should address the precise nature
of e¡ector(s) and regulators of Csps.
Acknowledgements: We are indebted to D. Nappey, D. Duhamel, A.
Gjinovci, J. Bassi and M. Wyss for skilled technical assistance. We
gratefully acknowledge the help of Dr M.-L. Piallat with the confocal
microscopy. We are grateful to Dr J. Pouyssegur for kindly providing
to us the plasmid pNHE3 and his protocol for acid-load selection. We
thank Dr O. Nuesse for critical reading of the manuscript and Dr M.
Seagar for stimulating discussions. This study was supported by re-
search grants from the Sandoz Foundation, the Roche Research
Foundation (to J.L.), the Karl-Mayer-Stiftung and by the Swiss Na-
tional Science Foundation Grant No. 32-49755.96 (to C.B.W. and
J.L.). W.K. acknowledges Dr C. Georgopoulos for ¢nancial support
(FN 31-47283-96).
References
[1] Martin, T.F.J. (1997) Trends Cell Biol. 7, 271^276.
[2] Augustine, G.J., Burns, M.E., Debello, W.M., Pettit, D.L. and
Schweizer, F.E. (1996) Annu. Rev. Pharmacol. Toxicol. 36, 659^
701.
[3] Zinsmaier, K.E., Hofbauer, A., Heimbeck, G., P£ugfelder,
G.O., Buchner, S. and Buchner, E. (1990) J. Neurogenet. 7,
15^29.
[4] Gundersen, C.B., Mastrogiacomo, A., Faull, K. and Umbach,
J.A. (1994) J. Biol. Chem. 269, 19197^19199.
[5] Buchner, E. and Gundersen, C.B. (1997) Trends Neurosci. 20,
223^227.
[6] Umbach, J.A., Zinsmaier, K.E., Eberle, K.K., Buchner, E., Benz-
er, S. and Gundersen, C.B. (1994) Neuron 13, 899^907.
[7] Zinsmaier, K.E., Eberle, K.K., Buchner, E., Walter, N. and
Benzer, S. (1994) Science 263, 977^980.
[8] Gundersen, C.B. and Umbach, J.A. (1992) Neuron 9, 527^537.
[9] Umbach, J.A. and Gundersen, C.B. (1997) J. Neurosci. 17, 7203^
7209.
FEBS 20992 27-10-98 Cyaan Magenta Geel Zwart
Fig. 4. Suppression of Csp1 expression inhibits exocytosis of insulin.
A: Cells transiently co-transfected with pNHE3 and either pcDNA3
(control) or pcDNA3asCsp encoding Csp antisense cDNA (anti-
sense) were puri¢ed as described in Section 2. Subsequently cell ho-
mogenates were used for the determination of Csp, syntaxin 1,
VAMP and SNAP-25 expression levels by immunoblots. B: HIT-
T15 cells were transiently co-transfected with a plasmid encoding
human preproinsulin as reporter gene and with either control vector
pcDNA3 (control, open bars) or pcDNA3asCsp encoding Csp anti-
sense (antisense, ¢lled bars). Eight days later human insulin C-pep-
tide secretion was quantitated as a measure of insulin exocytosis.
Upper panel: Secretion from intact cells under basal conditions
(KRB, Krebs-Ringer bu¡er) or after stimulation with 50 mM KCl
for 8 min. N = 6 from 3 independent experiments; * 2P6 0.05. Low-
er panel: Cells were permeabilised with streptolysin-O and exposed
to basal (0.1 WM) or maximally stimulatory (10 WM) levels of free
Ca2. N = 6 from 3 independent experiments; * 2P6 0.05.
H. Zhang et al./FEBS Letters 437 (1998) 267^272 271
[10] Ranjan, R., Bronk, P. and Zinsmaier, K.E. (1998) J. Neurosci.
18, 956^964.
[11] Umbach, J.A., Saitoe, M., Kidokoro, Y. and Gundersen, C.B.
(1998) J. Neurosci. 18, 3233^3240.
[12] Wollheim, C.B., Lang, J. and Regazzi, R. (1996) Diabetes Rev. 4,
277^297.
[13] Regazzi, R. et al. (1995) EMBO J. 14, 2723^2730.
[14] Wheeler, M.B. et al. (1996) Endocrinology 137, 1340^1348.
[15] Lang, J., Zhang, H., Vaidyanathan, V.V., Sadoul, K., Niemann,
H. and Wollheim, C.B. (1997) FEBS Lett. 419, 13^17.
[16] Martin, F., Moya, F., Gutierrez, L.M., Reig, J.A. and Soria, B.
(1995) Diabetologia 38, 860^863.
[17] Kiraly-Borri, C., Morgan, A., Burgoyne, R., Weller, U., Woll-
heim, C. and Lang, J. (1996) Biochem. J. 314, 199^203.
[18] Sadoul, K., Lang, J., Montecucco, C., Weller, U., Regazzi, R.,
Catsicas, S., Wollheim, C.B. and Halban, P.A. (1995) J. Cell
Biol. 128, 1019^1028.
[19] Lang, J., Fukuda, M., Zhang, H., Mikoshiba, K. and Wollheim,
C.B. (1997) EMBO J. 16, 5837^5846.
[20] Mizuta, M., Kurose, T., Miki, T., Shojikasai, Y., Takahashi, M.,
Seino, S. and Matsukura, S. (1997) Diabetes 46, 2002^2006.
[21] Weller, U. et al. (1996) Eur. J. Biochem. 236, 34^39.
[22] Chamberlain, L.H. and Burgoyne, R.D. (1996) J. Biol. Chem.
271, 7320^7323.
[23] Counillon, L., Scholz, W., Lang, H.J. and Pouyssegur, J. (1993)
Mol. Pharmacol. 44, 1041^1045.
[24] Chamberlain, L.H., Henry, J. and Burgoyne, R.D. (1996) J. Biol.
Chem. 271, 19514^19517.
[25] Lang, J., Ushkaryov, Y., Grasso, A. and Wollheim, C.B. (1998)
EMBO J. 17, 648^657.
[26] Zhang, H., Yasrebi-Nejad, H. and Lang, J. (1998) FEBS Lett.
424, 202^206.
[27] Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P.A. and Woll-
heim, C.B. (1992) Endocrinology 130, 167^178.
[28] Lang, J., Boulay, F., Li, G. and Wollheim, C.B. (1993) EMBO J.
12, 2671^2679.
[29] Lang, J., Nishimoto, I., Okamoto, T., Regazzi, R., Kiraly, C.,
Weller, U. and Wollheim, C.B. (1995) EMBO J. 14, 3635^
3644.
[30] Miyazaki, J., Araki, K., Yamato, E., Ikegami, H., Asano, T.,
Shibasaki, Y., Oka, Y. and Yamamura, K. (1990) Endocrinology
127, 126^132.
[31] Lang, J., Regazzi, R. and Wollheim, C.B. (1997) in: Bacterial
Toxins: Tools in Cell Biology (Aktories, K., Ed.) pp. 217^240,
Chapman and Hall, Weinheim.
[32] Lavoie, J.N., L’Allemain, G., Brunet, A., Rolf Muºller, R. and
PouysseŁgur, J. (1996) J. Biol. Chem. 271, 20608^20616.
[33] Reetz, A., Solimena, M., Matteoli, M., Folli, F., Takei, K. and
De Camilli, P. (1991) EMBO J. 10, 1275^1284.
[34] Cameron, P.L., Suºdhof, T.C., Jahn, R. and De Camilli, P. (1991)
J. Cell Biol. 115, 151^164.
[35] Mastrogiacomo, A., Parsons, S.M., Zampighi, G.A., Jenden,
D.J., Umbach, J.A. and Gundersen, C.B. (1994) Science 263,
981^982.
[36] Pupier, S., Leveque, C., Marqueze, B., Kataoka, M., Takahashi,
M. and Seagar, M.J. (1997) J. Neurosci. 17, 2722^2777.
[37] Braun, J.E. and Scheller, R.H. (1995) Neuropharmacology 34,
1361^1369.
[38] Li, G., Regazzi, R., Balch, W.E. and Wollheim, C.B. (1993)
FEBS Lett. 327, 145^149.
[39] Chamberlain, L.H. and Burgoyne, R.D. (1998) Mol. Biol. Cell 9,
2259^2267.
[40] Stanley, E.F. (1997) Trends Neurosci. 20, 404^409.
[41] Leveque, C. et al. (1992) Proc. Natl. Acad. Sci. USA 89, 3625^
3629.
[42] Sheng, Z.H., Rettig, J., Cook, T. and Catterall, W.A. (1996)
Nature 379, 451^454.
[43] Charvin, N. et al. (1997) EMBO J. 16, 4591^4596.
[44] Leveque, C., Pupier, S., Marqueze, B., Geslin, L., Kataoka, M.,
Takahashi, M., DeWaard, M. and Seagar, M. (1998) J. Biol.
Chem. 273, 13488^13492.
[45] Braun, J.E.A., Wilbanks, S.M. and Scheller, R.H. (1996) J. Biol.
Chem. 271, 25989^25993.
[46] Kelley, W.L. (1998) Trends Biochem. Sci. 23, 222^227.
[47] Ashcroft, F.M., Proks, P., Smith, P.A., Ammala, C., Bokvist, K.
and Rorsman, P. (1994) J. Cell Biochem. 55 Suppl., 54^65.
[48] Wiser, O., Bennett, M.K. and Atlas, D. (1996) EMBO J. 15,
4100^4110.
[49] Bokvist, K., Eliasson, L., Ammala, C., Renstrom, E. and Rors-
man, P. (1995) EMBO J. 14, 50^57.
FEBS 20992 27-10-98 Cyaan Magenta Geel Zwart
H. Zhang et al./FEBS Letters 437 (1998) 267^272272
